207 related articles for article (PubMed ID: 21321929)
1. The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts.
Bujor AM; Asano Y; Haines P; Lafyatis R; Trojanowska M
Arthritis Rheum; 2011 Jun; 63(6):1729-37. PubMed ID: 21321929
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.
Hinchcliff M; Huang CC; Ishida W; Fang F; Lee J; Jafari N; Wilkes M; Bhattacharyya S; Leof E; Varga J
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S86-96. PubMed ID: 22691216
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma.
Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2012 Nov; 167(5):1098-105. PubMed ID: 22591006
[TBL] [Abstract][Full Text] [Related]
4. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.
Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M
Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro.
Li Z; Jimenez SA
Arthritis Rheum; 2011 Aug; 63(8):2473-83. PubMed ID: 21425122
[TBL] [Abstract][Full Text] [Related]
6. A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.
Bhattacharyya S; Ishida W; Wu M; Wilkes M; Mori Y; Hinchcliff M; Leof E; Varga J
Oncogene; 2009 Mar; 28(10):1285-97. PubMed ID: 19151753
[TBL] [Abstract][Full Text] [Related]
7. Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.
Miyagawa T; Ichimura Y; Nakamura K; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Taniguchi T; Akamata K; Yoshizaki A; Sato S; Asano Y
J Dermatol Sci; 2018 Nov; 92(2):207-214. PubMed ID: 30268392
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
Wang S; Wilkes MC; Leof EB; Hirschberg R
FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
10. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.
Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH
Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
Akamata K; Asano Y; Yamashita T; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
Arthritis Rheumatol; 2015 May; 67(5):1335-44. PubMed ID: 25707716
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.
Piera-Velazquez S; Makul A; Jiménez SA
Arthritis Rheumatol; 2015 Oct; 67(10):2749-58. PubMed ID: 26096997
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts.
Piera-Velazquez S; Jimenez SA
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):36-44. PubMed ID: 30277861
[TBL] [Abstract][Full Text] [Related]
15. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.
Asano Y; Trojanowska M
Mol Cell Biol; 2009 Apr; 29(7):1882-94. PubMed ID: 19158279
[TBL] [Abstract][Full Text] [Related]
17. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage.
Wie SM; Adwan TS; DeGregori J; Anderson SM; Reyland ME
J Biol Chem; 2014 Apr; 289(15):10900-10908. PubMed ID: 24569990
[TBL] [Abstract][Full Text] [Related]
20. C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.
Xia CQ; Zhang P; Li S; Yuan L; Xia T; Xie C; Clare-Salzler MJ
PLoS One; 2014; 9(5):e97694. PubMed ID: 24835010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
